Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

INTRODUCTION: Immune checkpoint inhibitors (ICIs) are effective in the treatment of advanced esophageal squamous cell carcinoma (ESCC); however, their efficacy in locally advanced resectable ESCC and the potential predictive biomarkers have limited data. METHODS: In this study, locally advanced rese...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wenwu, Leng, Xuefeng, Mao, Tianqin, Luo, Xi, Zhou, Lingxiao, Yan, Jiaxin, Peng, Lin, Fang, Qiang, Liu, Guangyuan, Wei, Xing, Wang, Kangning, Wang, Chenghao, Zhang, Sha, Zhang, Xudong, Shen, Xudong, Huang, Depei, Yi, Huan, Bei, Ting, She, Xueke, Xiao, Wenguang, Han, Yongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842349/
https://www.ncbi.nlm.nih.gov/pubmed/35305102
http://dx.doi.org/10.1093/oncolo/oyab011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842349/
https://www.ncbi.nlm.nih.gov/pubmed/35305102
http://dx.doi.org/10.1093/oncolo/oyab011

Ejemplares similares